Literature DB >> 30279800

A daytime normotensive patient with nocturnal hypoxia-induced hypertension and severe obstructive sleep apnea.

Hiromitsu Sekizuka1,2, Satoshi Hoshide3, Naohiko Osada1, Yoshihiro J Akashi1, Kazuomi Kario3.   

Abstract

This is the case of a 60-year-old male. He had no past medical history at a regular medical check-up. According to findings at the regular medical check-up, he was obese (body mass index, 32.8 kg/m2), and had short neck, small jaw, and low soft palate; therefore, it was suspected that he may have sleep-disordered breathing. Blood pressure (BP) at the medical check-up was 121/80 mmHg, and the results of electrocardiogram and chest radiography were normal. Blood test data at the medical check-up indicated abnormality of lipid metabolism and hyperuricemia. No other abnormalities were found. It became clear that he became sleepy during daytime at an additional medical interview. Accordingly, he was diagnosed as having severe obstructive sleep apnea (OSA) with apnea-hypopnea index 65.3/h and arousal index 64.4/h by polysomnography. The oxygen-triggered nocturnal BP monitoring that was conducted at home around the same time indicated remarkable hypoxia-induced hypertension (Day 1: hypoxia-peak nocturnal BP 181/117 mmHg, Day 2: hypoxia-peak nocturnal BP 204/137 mmHg). The patient recognized the risk of OSA by visualizing the hypoxia-induced hypertension; therefore, introduction of continuous positive airway pressure (CPAP) therapy for severe OSA was smooth. As the results of CPAP therapy, we could confirm disappearance of hypoxia-induced hypertension. <Learning objective: An office worker without cardiovascular disease was diagnosed as having severe obstructive sleep apnea. Remarkable hypoxia-induced nocturnal hypertension was identified by oxygen-triggered blood pressure (BP) monitoring. It was considered that nocturnal hypertension, which was not able to be recorded by previous ambulatory blood pressure monitoring, was recorded by the oxygen-triggered BP monitoring method.>.

Entities:  

Keywords:  Desaturation; Polysomnography; Sleep blood pressure; Sleep disordered breathing; Visualization

Year:  2017        PMID: 30279800      PMCID: PMC6149270          DOI: 10.1016/j.jccase.2017.05.003

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

Review 1.  Peripheral chemoreceptors: function and plasticity of the carotid body.

Authors:  Prem Kumar; Nanduri R Prabhakar
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

2.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).

Authors:  Kazuaki Shimamoto; Katsuyuki Ando; Toshiro Fujita; Naoyuki Hasebe; Jitsuo Higaki; Masatsugu Horiuchi; Yutaka Imai; Tsutomu Imaizumi; Toshihiko Ishimitsu; Masaaki Ito; Sadayoshi Ito; Hiroshi Itoh; Hiroshi Iwao; Hisashi Kai; Kazuomi Kario; Naoki Kashihara; Yuhei Kawano; Shokei Kim-Mitsuyama; Genjiro Kimura; Katsuhiko Kohara; Issei Komuro; Hiroo Kumagai; Hideo Matsuura; Katsuyuki Miura; Ryuichi Morishita; Mitsuhide Naruse; Koichi Node; Yusuke Ohya; Hiromi Rakugi; Ikuo Saito; Shigeyuki Saitoh; Kazuyuki Shimada; Tatsuo Shimosawa; Hiromichi Suzuki; Kouichi Tamura; Norio Tanahashi; Takuya Tsuchihashi; Makoto Uchiyama; Shinichiro Ueda; Satoshi Umemura
Journal:  Hypertens Res       Date:  2014-04       Impact factor: 3.872

3.  Development and clinical application of a new technique for detecting 'sleep blood pressure surges' in sleep apnea patients based on a variable desaturation threshold.

Authors:  Osamu Shirasaki; Mitsuo Kuwabara; Minako Saito; Kayoko Tagami; Sumio Washiya; Kazuomi Kario
Journal:  Hypertens Res       Date:  2011-05-26       Impact factor: 3.872

4.  Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial.

Authors:  Ferran Barbé; Joaquín Durán-Cantolla; Manuel Sánchez-de-la-Torre; Montserrat Martínez-Alonso; Carmen Carmona; Antonia Barceló; Eusebi Chiner; Juan F Masa; Mónica Gonzalez; Jose M Marín; Francisco Garcia-Rio; Josefa Diaz de Atauri; Joaquín Terán; Mercedes Mayos; Mónica de la Peña; Carmen Monasterio; Felix del Campo; Josep M Montserrat
Journal:  JAMA       Date:  2012-05-23       Impact factor: 56.272

5.  Recurrence of stroke caused by nocturnal hypoxia-induced blood pressure surge in a young adult male with severe obstructive sleep apnea syndrome.

Authors:  Tetsuro Yoshida; Mitsuo Kuwabara; Satoshi Hoshide; Kazuomi Kario
Journal:  J Am Soc Hypertens       Date:  2016-01-25

6.  Day-night pattern of sudden death in obstructive sleep apnea.

Authors:  Apoor S Gami; Daniel E Howard; Eric J Olson; Virend K Somers
Journal:  N Engl J Med       Date:  2005-03-24       Impact factor: 91.245

7.  Relationship between sleep apnea syndrome and sleep blood pressure in patients without hypertension.

Authors:  Hiromitsu Sekizuka; Keisuke Kida; Yoshihiro J Akashi; Kihei Yoneyama; Naohiko Osada; Kazuto Omiya; Fumihiko Miyake
Journal:  J Cardiol       Date:  2009-11-22       Impact factor: 3.159

8.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study.

Authors:  José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen
Journal:  Lancet       Date:  2007-10-06       Impact factor: 79.321

Review 9.  Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control.

Authors:  Kazuomi Kario
Journal:  Hypertens Res       Date:  2009-05-22       Impact factor: 3.872

10.  Novel Triggered Nocturnal Blood Pressure Monitoring for Sleep Apnea Syndrome: Distribution and Reproducibility of Hypoxia-Triggered Nocturnal Blood Pressure Measurements.

Authors:  Mitsuo Kuwabara; Haruna Hamasaki; Naoko Tomitani; Toshikazu Shiga; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-14       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.